CARsgen Therapeutics

CARsgen Therapeutics Overview

Company Headquarter: Shanghai, China

Founded: 2014

Workforce: ~200

Company Working: CARsgen Therapeutics (CARsgen) is a clinical-stage immune-oncology company focused on the development of CAR-T therapeutics. The company primarily operates in China and the US. The company has established a broad pipeline of CAR-T product candidates covering several solid and blood tumors in areas of significant unmet medical needs. The company launched several clinical trials for the treatment of relapsed/refractory tumors, including CAR-GPC3-T trial for hepatocellular carcinoma (HCC) and squamous lung cancer, CAR-EGFR/EGFRvIII-T trial for glioblastoma, and CAR-Claudin18.2-T for gastric and pancreatic cancer. CARsgen also has ongoing clinical programs with a humanized CAR-CD19-T trial for leukemia and a fully human CAR-BCMA-T trial for multiple myeloma. CARsgen intends to submit five investigational new drugs (IND) to the National Medical Products Administration (NMPA), China, and 2 INDs to the FDA in 2019.

Strategy

CARSgen aims to offer innovative CAR T-cell therapies for cancer patients worldwide. It is also focused on engaging in strategic partnerships with academic institutes and hospitals to become a preferred partner for CAR T cell therapies

Company Snapshot

200

Employees

2014

Founded

SWOT Analysis

Strengths

Strong product pipeline

Weaknesses

Manufacturing facilities limited to China and US

Opportunities

Geographic expansion through mergers

Threats

Tough market competition
Extensive regulations

Product Offering

CARsgen Therapeutics
- Pipeline

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.